Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gruber

Showing results (291-300 of 355) with videos related to

Pageof 36
Sort By:
Vaccine|August 23, 2013
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing scheduleGail L Rodgers, Susanna Esposito, Nicola Principi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 12, 2018
The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) StudyAnna M M van Deursen, Marlies A van Houten, Chris Webber, et al.
The Lancet. Child & Adolescent Health|June 18, 2026
Immunogenicity and safety of a pentavalent meningococcal MenABCWY vaccine in healthy adolescents and young adults: a phase 3, multicountry, randomised, observer-blinded, active-controlled non-inferiority trialLars Ostergaard, Hanna Czajka, Lilia Roque-Guerrero, et al.
Open Forum Infectious Diseases|July 21, 2025
Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South AfricaShabir A Madhi, Eric A F Simões, Nicola P Klein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2023
Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older AdultsEugene Athan, James Baber, Karen Quan, et al.
Vaccine|July 21, 2009
A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young childrenRobert F Breiman, W Abdullah Brooks, Doli Goswami, et al.
The Netherlands Journal of Medicine|November 8, 2008
Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adultsE Hak, D E Grobbee, E A M Sanders, et al.
Journal of Medicinal Chemistry|August 10, 2001
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activityH R Tsou, N Mamuya, B D Johnson, et al.
Scientific Reports|August 25, 2022
Structural bioinformatics analysis of SARS-CoV-2 variants reveals higher hACE2 receptor binding affinity for Omicron B.1.1.529 spike RBD compared to wild type referenceVedat Durmaz, Katharina Köchl, Andreas Krassnigg, et al.
Clinical and Vaccine Immunology : CVI|June 8, 2012
Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urineMichael W Pride, Susanne M Huijts, Kangjian Wu, et al.
Pageof 36

Showing results (291-300 of 355) with videos related to

Sort By:
Pageof 36
Vaccine|August 23, 2013
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing scheduleGail L Rodgers, Susanna Esposito, Nicola Principi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 12, 2018
The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) StudyAnna M M van Deursen, Marlies A van Houten, Chris Webber, et al.
The Lancet. Child & Adolescent Health|June 18, 2026
Immunogenicity and safety of a pentavalent meningococcal MenABCWY vaccine in healthy adolescents and young adults: a phase 3, multicountry, randomised, observer-blinded, active-controlled non-inferiority trialLars Ostergaard, Hanna Czajka, Lilia Roque-Guerrero, et al.
Open Forum Infectious Diseases|July 21, 2025
Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South AfricaShabir A Madhi, Eric A F Simões, Nicola P Klein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2023
Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older AdultsEugene Athan, James Baber, Karen Quan, et al.
Vaccine|July 21, 2009
A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young childrenRobert F Breiman, W Abdullah Brooks, Doli Goswami, et al.
The Netherlands Journal of Medicine|November 8, 2008
Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adultsE Hak, D E Grobbee, E A M Sanders, et al.
Journal of Medicinal Chemistry|August 10, 2001
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activityH R Tsou, N Mamuya, B D Johnson, et al.
Scientific Reports|August 25, 2022
Structural bioinformatics analysis of SARS-CoV-2 variants reveals higher hACE2 receptor binding affinity for Omicron B.1.1.529 spike RBD compared to wild type referenceVedat Durmaz, Katharina Köchl, Andreas Krassnigg, et al.
Clinical and Vaccine Immunology : CVI|June 8, 2012
Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urineMichael W Pride, Susanne M Huijts, Kangjian Wu, et al.
Pageof 36